期刊文献+

造血干细胞移植后免疫重建

Reconstitution of the immune system after hematopoietic stem cell transplantation
原文传递
导出
摘要 造血干细胞移植(HSCT)已广泛应用于临床,是治疗血液系统疾患、实体瘤、基因缺陷及自身免疫性疾病的重要手段干细胞移植伴随着严重的免疫缺陷,这一时期,患者有合并严重感染的风险固有免疫恢复迅速.NK细胞、树突状细胞移植后数周内即可恢复。而适应性免疫系统恢复缓慢,T细胞和B细胞移植后数月才可恢复正常,而T细胞功能恢复需要数年的时间:研究造血系统各细胞存移植后数量、功能上的恢复规律,对如何加快免疫重建,降低移植死亡率有重要意义. Hematopoietic stem cell transplantation (HSCT) has been widely used in clinical practice. It has become an important treatment for hematological disorders, solid tumors, genetic defects and autoimmune diseases. HSCT is associated with severe immune deficiency. As a result, patients receiving HSCT are at high risk of infections. Innate immunity, including NK cell and dendritic cells, recovers within weeks after transplantation. By contrast, adaptive immunity recovers much slower. B- and T-cell counts return to normal level during the first few months after transplantation. However, T-cell',immunity may remain impaired for years. To study the quantitative and functional of recovery of cells in the hematopoietic system is vital important for the understanding of how to accelerate immune reconstitution and to reduce transplant mortality.
出处 《国际免疫学杂志》 CAS 北大核心 2010年第2期144-147,共4页 International Journal of Immunology
关键词 造血干细胞移植 免疫重建 T细胞 B细胞 自然杀伤细胞 Hematopoietic stem cell transplantation Immune reconstitution T cell B cell Natural killer cell
  • 相关文献

参考文献19

  • 1Zhang Y,Wallace DL,de Lara CM,et al.In vivo kinetics of human natural killer cells:the effects of ageing and acute and chronic viral infection.Immunology,2007,121(2):258-265.
  • 2Savani BN,Rezvani K,Mielke S,et al.Factors associated with early molecular remission after T celldepleted allogeneic stem cell transplantation for chronic myelogenous leukemia.Blood,2006,107(4):1688-1695.
  • 3Farag SS,Bacigalupo A,Eapen M,et al.The effect of KIR ligand incompatibility on the outcome of unrelated donor transplantation:a report from the Center for International Blood and Marrow Transplant Research,the European Blood and Marrow Transplant Registry,and the Dutch Registry.Biol Blood Marrow Transplant,2006,12 (8):876-84.
  • 4Dulphy N,Haas P,Busson M,et al.An unusual CD56(bright) CD16(low) NK cell subset dominates the early posttransplant period following HLA-matched hematopoietic stem cell transplantation.J Immunol,2008,181(3):2227-2237.
  • 5Lu X,Kondo Y,Takamatsu H,Ohata K,et al.CD16^+ CD56^-NK cells in the peripheral blood of cord blood transplant recipients:a unique subset of NK cells possibly associated with graft-versus-leukemia effect.Eur J Haematol,2008,81(1):18-25.
  • 6Larosa F,Mrmier C,Robinet E,et al.Peripheral T-cell expansion and low infection rate after reduced-intensity conditioning and allogeneic blood stem cell transplantation.Bone Marrow Transplantation,2005,35(9):859-868.
  • 7苏永锋,江小霞.微环境与树突状细胞的发育[J].国际免疫学杂志,2007,30(5):323-326. 被引量:1
  • 8Bogunovic M,Cinhoux F,Wagers A,et al.Identification of a radio-resistant and cycling dermal dendritic cell population in mice and men.J Exp Med,2006,203(12):2627-2638.
  • 9Mackall CL,Granger L,Sheard MA,et al.Gress RE T-cell regeneration after bone marrow transplantation:Differential CD45 isoform expression on thymic-derived versus thymic-independent progeny.Blood,1993,82(8):2585-2594.
  • 10Olkinuora H,Talvensaari K,Kaartinen T,et al.T cell regeneration in pediatric allogeneic stem cell transplantation.Bone Marrow Transplantation,2007,39 (3):149-156.

二级参考文献18

  • 1厉倩,曹雪涛(审校者).树突状细胞与免疫负向调控[J].国际免疫学杂志,2006,29(1):48-51. 被引量:9
  • 2Zhang M ,Tang H, Guo Z, et al. Splenic stroma drives mature dendritic cells to differentiate into regulatory dendritic cells. Nat Immunol, 2004 , 5(11) :1124-1133.
  • 3Svensson M, Mroof A, Ato m, et al. Stromal cells direct local differentiation of regulatory dendritic cells. Immunity, 2004 , 21 (6) :805- 816.
  • 4Tang H, Guo Z, Zhang M,et al. Endothelial stroma programs hematopoietic stem cells to differentiate into regulatory dendritic cells through IL-10. Blood, 2006 108(4):1189-1197.
  • 5Randoiph GJ. Bwaulieu S. Lebecque S. et al. Differentiation of monocytes into dendritic cells in a model of transendothelial trafficking. Science, 1998 ,282(5388) :480-483.
  • 6Moldenhauer A, Nociari M, Lam G,et al. Tumor Necrosis Factor Alpha-Stimulated Endothelium: An Inducer of Dendritic Cell Development from Hematopoietic Progenitors and Myeloid Leukemic Cells. Stem Cells, 2004, 22(2) : 144-157.
  • 7Jiang XX,Zhang Y, Liu B, et al. Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells. Blood, 2005 May 15,105(10) :4120-4126.
  • 8Nauta AJ, Kruisselbrink AB, Lurvink E, et al. Mesenchymal stem cells inhibit generation and function of both CD34^+ -derived and monocyte-derived dendritic cells. J Immunol, 2006 , 177 (4) : 2080-2087.
  • 9Ramasamy R, Fazekasova H, Lam EW, et al . Mesenchymal stem cells inhibit dendritic cell differentiation and function by preventing entry into the cell cycle. Transplantation, 2007 ,83( 1 ) :71-76,
  • 10Briard D, Azzarone B, Brouty-boye D. Importance of stromal determinants in the generation of dendritic and natural killer cells in the human spleen. Clin Exp Immunol, 2005 , 140(2) :265-273.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部